› $150,000,000 verdict in personal injury case
Retired NBA player Manute Bol is in the hospital with kidney failure and Stevens Johnson Syndrome (SJS), a life-threatening skin condition. The former Washington Bullets center was hospitalized in Northern Virginia after spending several months in his hometown of Sudan. Bol was building a school there through the group Sudan Sunrise. According to Bol’s facebook page, the former NBA player developed SJS after taking medication.
A Texas man is suing the maker of his anti-epileptic drugs claiming the medications caused him to develop a severe skin reaction known as Stevens Johnson Syndrome, or SJS, according to the West Virginia Record.
It’s been almost a year since we last checked in on Rachel Corley-Gutierrez, better known by her YouTube moniker, SpunkyRachel. The young woman was diagnosed with the rare but life threatening allergic reaction to medication known as Stevens Johnson Syndrome (SJS) just two weeks after taking ibuprofen for a headache. Her YouTube video diaries track her long and painful road to recovery. Her latest update is encouraging.
A medication approved by the Food and Drug Administration (FDA) to treat migraine headaches is scheduled to become available in the United States this month. Cambia (diclofenac potassium for oral solution) was found to reduce migraine pain within 30 minutes, according to a study published in Cephalalgia, the international journal of headache.
A newly approved drug for the treatment of arthritis in patients at risk of developing NSAID-associated gastric ulcers has been linked to a rare but serious hypersensitivity disorder known as Stevens Johnson Syndrome (SJS).
My son was 2.5 years old when he was admitted to the Children’s Hospital on Nov 7th, 2009, in Winnipeg, MB Canada. I also had never heard of SJS. Today, it is all I think about.
The mother of young Liam refers to herself simply as Melanie. But she so identified with Avi Selk’s recent Dallas Morning News story about a rare skin condition known as Stevens Johnson Syndrome, or SJS, that she felt compelled to comment on the story.
A new study on the side effects of Accutane published in the American Journal of Gastroenterology suggest that the acne drug may increase the risk of developing bowel problems. The findings come just weeks after a New Jersey jury awarded an Alabama man $25.16 million because they believed Roche’s Accutane caused the man to develop inflammatory bowel disease (IBD), a group of digestive disorders that includes ulcerative colitis and Crohn’s disease.
A medicine used to treat and help prevent the flu may put patients at risk for a rare but life-threatening condition in which the skin peels off the body in sheets, according to the Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research. The agency notified the public that it has approved safety label changes for Relenza (zanamivir) Inhalation Powder for oral inhalation. The Adverse Reactions section of the drug’s new safety label now includes a risk of rash, including serious cutaneous reactions (e.g. erythema multiforme, Stevens Johnson Syndrome, SJS, and toxic epidermal necrolysis, TEN).
A medication used for the management of hypertension now includes an updated safety label that warns patients of a rare but serious skin condition, according to the Food and Drug Administration (FDA)’s Safety Information and Adverse Event Reporting Program. The new safety label for Inderide (propranolol HCL/hydrochlorothiazide) tablets carries a warning of “erythema multiforme including Stevens Johnson Syndrome (SJS), exfoliative dermatitis, including toxic epidermal necrolysis (TEN)” in the Adverse Reactions section.
A drug used to treat acid reflux disease has been linked to a rare but serious skin condition known as Stevens Johnson Syndrome (SJS) and its more severe form, toxic epidermal necrolysis (TEN), according to the Food and Drug Administration (FDA). Dexilant (dexlansoprazole) delayed release capsules now includes a warning of the risk of SJS and TEN in the Adverse Reactions section of its safety label. The updated label states that in post-marketing review, some patients taking Dexilant suffered immune system disorders including anaphylactic shock that required emergency intervention, and SJS and TEN. Some cases were fatal.
